Archive - June 2022
Almirall shares positive topline results from atopic dermatitis trials
Pfizer to expand Paxlovid manufacturing in US to meet global demand
Bachem and Eli Lilly link up to advance oligonucleotide products
Vertex trial for hypoglycaemia therapy shows early promise
FDA Approves Riabni (rituximab-arrx), a Biosimilar to Rituxan (rituximab), for Adults with Moderate to Severe Rheumatoid Arthritis
CDC Recommends Wearing Masks Due To Another Disease Spreading Globally
Inhaled Vaccine For COVID-19: The Pandemic Accelerated Decades Of Research Leading To Jab-Free Vaccine Now In Human Testing
FDA Approves Dupixent (dupilumab) as First Biologic Medicine for Children Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis